Intercept Pharmaceuticals Inc Capitalisation boursière
Quel est le Capitalisation boursière de Intercept Pharmaceuticals Inc?
Le Capitalisation boursière de Intercept Pharmaceuticals Inc est $460.93M
Quelle est la définition de Capitalisation boursière?
La capitalisation boursière est la valeur marchande à un moment donné des actions en circulation d'une société cotée en bourse, étant égale au cours de l' action à ce moment-là, multiplié par le nombre d'actions en circulation .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Capitalisation boursière des entreprises dans Health Care secteur sur NASDAQ par rapport à Intercept Pharmaceuticals Inc
Que fait Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Entreprises avec capitalisation boursière similaire à Intercept Pharmaceuticals Inc
- Carter Bank & Trust a Capitalisation boursière de $459.11M
- Custom Truck One Source Inc a Capitalisation boursière de $459.62M
- Gateway Distriparks a Capitalisation boursière de $460.03M
- Similarweb a Capitalisation boursière de $460.69M
- I.T a Capitalisation boursière de $460.69M
- PM Capital Global Opportunities Fund a Capitalisation boursière de $460.80M
- Intercept Pharmaceuticals Inc a Capitalisation boursière de $460.93M
- Pierre & Vacances SA a Capitalisation boursière de $461.00M
- Smith & Wesson Brands a Capitalisation boursière de $461.24M
- Cardinal Resources a Capitalisation boursière de $461.84M
- Invesco Mortgage Capital Inc a Capitalisation boursière de $461.86M
- Greatland Gold Plc a Capitalisation boursière de $461.87M
- Misonix Inc a Capitalisation boursière de $461.98M